English | Español
Press release submission | Jul 3, 2022

Innovent Announces First Patient Dosed in a Phase 2 Clinical study of IBI112 (IL-23p19 Monoclonal Antibody) in Patients with Moderate-to-Severe Active Ulcerative Colitis
Press release submission | Jul 1, 2022

More Surgical Care Cuts Take Effect Today, Harming Patients
Press release submission | Jul 1, 2022

FDA Declines Emergency Use Authorization for ZYESAMI® (aviptadil) for subgroup of Patients with Critical COVID-19 at immediate risk of death from respiratory failure despite treatment with approved therapy, including remdesivir

Press release submission | Jun 30, 2022

Big Win for Patients: Aetna Drops Prior Authorization for Most Cataract Surgeries

Press release submission | Jun 29, 2022

New Study: Oxaloacetate Reduces Chronic Fatigue In Just Six Weeks, Promising Data for ME/CFS Patients

Press release submission | Jun 24, 2022

BioFluidica Next-Generation Liquid Biopsy Platform Uncovers Undiagnosed HER2+ Patients

Press release submission | Jun 24, 2022

OM1 Launches a New Estimation Model for the Expanded Disability Status Score (EDSS) for Multiple Sclerosis Patients

Press release submission | Jun 23, 2022

CHMP issues a positive opinion recommending full approval of Oncopeptides Pepaxti in EU for patients with triple class refractory multiple myeloma

Trending
+ Technology/Innovation
Patient Daily News Service | Oct 9, 2025

Babylon Health collapse raises questions about AI claims across industries
Patient Daily | Oct 9, 2025

Medfluence Advisors Marketing Expert: 'The conversations leading into AAO-HNSF are shaping how ENT practices approach growth and engagement'
Patient Daily | Oct 9, 2025

AI takes center stage at ASCENT ENT conference, reshaping marketing and operations
+ Pharmaceuticals
Patient Daily | Oct 8, 2025

American Lung Association launches campaign urging vaccinations against seasonal flu and respiratory illnesses